Clinuvel Pharmaceuticals Limited (FRA:UR9A)
6.60
+0.05 (0.76%)
At close: Dec 4, 2025
-14.84% (1Y)
| Market Cap | 352.86M |
| Revenue (ttm) | 53.04M |
| Net Income (ttm) | 20.19M |
| Shares Out | n/a |
| EPS (ttm) | 0.40 |
| PE Ratio | 17.47 |
| Forward PE | 16.64 |
| Dividend | 0.02 (0.35%) |
| Ex-Dividend Date | Sep 8, 2025 |
| Volume | n/a |
| Average Volume | n/a |
| Open | 6.60 |
| Previous Close | 6.55 |
| Day's Range | 6.60 - 6.60 |
| 52-Week Range | 5.00 - 7.75 |
| Beta | n/a |
| RSI | 66.43 |
| Earnings Date | Nov 27, 2025 |